Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

NCT03437837 · clinicaltrials.gov ↗

COMPLETED

Status

1077

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoadjuvant Therapy
Neoplasm Staging
Estrogen Receptor
Histological Grade
HER2
Prognosis
Predictive Value of Tests

Sponsor

Peking University First Hospital